Marketing-authorisation holder · United States
Ajenat Pharms
5 medicines in 1 country, as authorisation holder.
Medicines
Every medicine in the registers under its name, current ones first.
5 medicines
| Medicine | Substance | Country | Status | Authorised |
|---|---|---|---|---|
| DESOXYN10mg | 15mg | 5mg · Tablet, extended release | Methamphetamine | United States | Not marketed | 1943 |
| DESOXYN5MG · Tablet | Methamphetamine | United States | Marketed | 1943 |
| TRANXENE15MG **Federal Register determination that product was not discontinued or withdrawn for safety or effectiveness reasons** | 3.75MG **Federal Register determination that product was not discontinued or withdrawn for safety or effectiveness reasons** | 7.5MG · Tablet | Potassium clorazepate | United States | Marketed | 1972 |
| TRANXENE15MG **Federal Register determination that product was not discontinued or withdrawn for safety or effectiveness reasons** | 3.75MG **Federal Register determination that product was not discontinued or withdrawn for safety or effectiveness reasons** | 7.5MG **Federal Register determination that product was not discontinued or withdrawn for safety or effectiveness reasons** · Capsule | Potassium clorazepate | United States | Not marketed | 1972 |
| TRANXENE SD11.25MG **Federal Register determination that product was not discontinued or withdrawn for safety or effectiveness reasons** | 22.5MG **Federal Register determination that product was not discontinued or withdrawn for safety or effectiveness reasons** · Tablet | Potassium clorazepate | United States | Not marketed | 1972 |
Countries
Where it holds or makes medicines, with how many are current.